OptiBiotix inks deal with Nutrilinea for hypertension supplement
20th May 2019 10:45
(Sharecast News) - Life sciences company OptiBiotix Health announces on Monday that its wholly-owned subsidiary ProBiotix Health has signed a license agreement with Nutrilinea for the use of its 'LPLDL' product in a food supplement for the reduction of high blood pressure, or hypertension.
Read moreOptiBiotix inks LPLDL deal with Spain's IENP
7th May 2019 12:13
(Sharecast News) - Life sciences business OptiBiotix Health announced on Tuesday that its wholly-owned subsidiary ProBiotix Health has signed a license agreement with Instituto Español de Nutrición Personalizada (IENP) for the use of 'lactobacillus plantarum' (LPLDL) in personalised food supplements in Spain.
Read moreOptiBiotix to launch SlimBiome Medical in UK market this month
24th Apr 2019 11:28
(Sharecast News) - Life sciences business OptiBiotix Health announced the launch of its weight management product 'SlimBiome Medical' to the UK market on Wednesday.
Read moreOptiBiotix partner gets approval to make SlimBiome in India
11th Apr 2019 11:16
(Sharecast News) - OptiBiotix Health announced on Thursday that it has received a licence from the Food Standards and Safety Authority India (FSSAI) for its weight management product 'SlimBiome' to be manufactured in the country.
Read moreOptiBiotix inks deal with DKSH for Italy and Spain markets
20th Mar 2019 07:41
(Sharecast News) - Life sciences company OptiBiotix Health has entered into an exclusive agreement with DKSH International to distribute its 'SlimBiome' proprietary weight management technology in Italy and Spain, it announced on Wednesday.
Read moreOptibiotix Health expands international reach through supply agreement
15th Mar 2019 08:16
(Sharecast News) - OptiBiotix Health on Friday extended a supply agreement to broaden the supply of cholesterol-lowering capsules into Germany and several other countries.
Read moreOptiBiotix up as LPLDL gets 'safe' status in US
21st Feb 2019 11:07
(Sharecast News) - Life sciences firm OptiBiotix Health confirmed on Thursday that its wholly-owned subsidiary ProBiotix Health has had its cholesterol and blood pressure reducing 'Lactobacillus plantarum LPLDL' probiotic strain determined as 'Generally Recognized As Safe' (GRAS) by an independent expert GRAS panel in the United States.
Read moreOptibiotix revenues soar in second half
13th Feb 2019 08:46
(Sharecast News) - Optibiotix Health's annual income soared in its last trading year as the healthy food additive maker continued to commercialise its products and grow sales.
Read moreOptiBiotix gains foothold in Japan with distibution deal
11th Feb 2019 12:32
(Sharecast News) - Optibiotix Health on Monday signed an agreement appointing EIWA Trading Co. as its exclusive distributor for its cholesterol and blood pressure-reducing probiotic strain LPLDL in Japan.
Read moreOptiBiotix extends CholBiome sales channel to Russia and Kazakhstan
9th Jan 2019 08:56
(Sharecast News) - OptiBiotix Health on Wednesday entered into a three-year distribution agreement for its own-brand CholBiome products in Russia and Kazakhstan.
Read moreOptiBiotix partners with Zeon Lifesciences for India market
7th Jan 2019 15:53
(Sharecast News) - Life sciences business OptiBiotix Health has entered into an exclusive manufacturing and supply agreement with Zeon Lifesciences, it announced on Monday.
Read moreOptiBiotix's 'SlimBiome' granted medical device status and CE mark
27th Nov 2018 14:17
(Sharecast News) - Life sciences business OptiBiotix Health announced on Tuesday that its 'SlimBiome' product has been granted medical device status and a CE mark.
Read moreOptiBiotix signs distribution agreement for Greece and Cyprus
22nd Nov 2018 16:00
(Sharecast News) - Life sciences business OptiBiotix Health has entered into a three-year distribution agreement with an unnamed company to exclusively distribute and commercialise its own-label 'CholBiome' products containing its cholesterol and blood pressure reducing 'LPLDL' strain in Greece and Cyprus.
Read moreOptiBiotix enters three-year distribution deal with Bulgarian partner
26th Sep 2018 13:47
(Sharecast News) - Life sciences business OptiBiotix Health has entered into a three-year distribution agreement with an unnamed Bulgarian company to exclusively distribute and commercialise its own-label 'CholBiome' products, containing its cholesterol and blood pressure reducing 'LPLDL' strain in Bulgaria, it announced on Wednesday.
Read moreOptiBiotix inks licence agreement with Taiwanese probiotics outfit
10th Sep 2018 09:12
(Sharecast News) - OptiBiotix Health has inked a non-exclusive licence agreement for its cholesterol and blood pressure-reducing LPLDL products with Taiwanese probiotics outfit Bened Biomedical.
Read more